Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXB2NC
|
||||
Drug Name |
CHEMBL2220375
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C42H70N6O5
|
||||
Canonical SMILES |
CCCCNC(=O)[C@H](C[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@H](CCCC)N2CCN([C@H](Cc3ccccc3)C2=O)C(=O)N4CCN(C)CC4)C(C)C
|
||||
InChI |
InChI=1S/C42H70N6O5/c1-6-8-20-36(40(51)44-35(28-32-16-12-10-13-17-32)38(49)30-34(31(3)4)39(50)43-21-9-7-2)47-26-27-48(42(53)46-24-22-45(5)23-25-46)37(41(47)52)29-33-18-14-11-15-19-33/h11,14-15,18-19,31-32,34-38,49H,6-10,12-13,16-17,20-30H2,1-5H3,(H,43,50)(H,44,51)/t34-,35+,36+,37-,38+/m1/s1
|
||||
InChIKey |
NGCGSAFHWCZMPV-LDVAZLSXSA-N
|
||||
Target and Pathway | |||||
Target(s) | Renin, renal | Target Info | [1587926] | ||
Cathepsin D | Target Info | [1587926] | |||
BioCyc Pathway | Thyroid hormone biosynthesis | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | LKB1 signaling events | ||||
Ceramide signaling pathway | |||||
Direct p53 effectors | |||||
Validated nuclear estrogen receptor alpha network | |||||
PathWhiz Pathway | Angiotensin Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.